热门资讯> 正文
Myriad Genetics宣布新的2亿美元信贷安排
2025-07-31 20:51
- 万基遗传(MYGN) 0
- 纳比特(NA) 0
- 盛大科技(SDA) 0
- Myriad Genetics (NASDAQ:MYGN) announced on Thursday it has closed a five-year senior secured term loan credit facility providing up to $200 million of capital from OrbiMed.
- The facility includes $125 million of funded capital with an option to borrow up to an additional $75 million until June 30, 2027.
- The facility matures on July 31, 2030, and bears interest at a rate based upon the one-month secured overnight financing rate (SOFR) plus 6.50% per year, subject to a SOFR floor of 2.50% per year, said the company.
- The company added that the new credit facility with OrbiMed replaces Myriad's previous ABL facility. The credit facility is secured by substantially all the assets of Myriad Genetics and its subsidiaries.
- MYGN +9.37% premarket to $4.4297.
- Source: Press Release
More on Myriad Genetics
- Myriad genetics lowers 2025 revenue guidance by $35M amid GeneSight challenges
- Myriad Genetics Non-GAAP EPS of -$0.03 beats by $0.02, revenue of $196M misses by $4.51M
- Seeking Alpha’s Quant Rating on Myriad Genetics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
